Skip to main content
    K

    Krystal Biotech Inc (KRYS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $297.90
    -7.33 (-2.40%)

    Market Cap: $9.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Krystal Biotech Inc (KRYS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Krystal Biotech are BridgeBio Pharma (BBIO), Crispr Therapeutics AG (CRSP) and TG Therapeutics (TGTX). Krystal Biotech trades at 40.4x earnings, against a median of 39.6x for the 3 of these companies with a P/E. By market cap, Krystal Biotech ranks 7th of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B.

    Peer Comparison

    KRYS's revenue growth of 30.2% is below the peer median of 136.1%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Krystal Biotech (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Bio-Techne Corp (TECH)$11.44B39.6x9.3x14.0%7.7%4.6%0.44%
    Kodiak Sciences Inc (KOD)$7.27BN/AN/A0.0%-1481.8%0.0%0.00%
    Protagonist Therapeutics Inc (PTGX)$8.55B27.7x15.8x62.0%N/A5724.0%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    Kymera Therapeutics Inc (KYMR)$10.89BN/A123.2x0.0%N/A466.4%0.00%
    Rhythm Pharmaceuticals Inc (RYTM)$7.97BN/A26.4x-69.0%-98.6%79.6%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Praxis Precision Medicines Inc (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Peer median$8.86B39.6x16.0x0.0%-26.6%136.1%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Krystal Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    BridgeBio Pharma Inc (BBIO)
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    Crispr Therapeutics AG (CRSP)
    CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.
    CRSP competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Bio-Techne Corp (TECH)
    Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments...
    TECH competitors
    Kodiak Sciences Inc (KOD)
    Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing...
    KOD competitors
    Protagonist Therapeutics Inc (PTGX)
    Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical...
    PTGX competitors
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    Kymera Therapeutics Inc (KYMR)
    Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down...
    KYMR competitors
    Rhythm Pharmaceuticals Inc (RYTM)
    Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment...
    RYTM competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    Praxis Precision Medicines Inc (PRAX)
    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal...
    PRAX competitors
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors

    Frequently Asked Questions About KRYS

    Who are Krystal Biotech's main competitors?

    The companies most similar to Krystal Biotech include BridgeBio Pharma (BBIO), Crispr Therapeutics AG (CRSP), TG Therapeutics (TGTX), Bio-Techne (TECH) and Kodiak Sciences (KOD), listed from the closest match.

    Who is Krystal Biotech's biggest competitor?

    BridgeBio Pharma (BBIO) is both the largest of the similar companies at $15.25B and the closest match by business profile, size, sector and industry.

    How does KRYS stock compare with its competitors?

    KRYS' P/E is 40.4x against a peer median of 39.6x; its P/S is 18.8x against a peer median of 16.0x; its net margin is 47.9% against a peer median of 0.0%.

    Which of Krystal Biotech's competitors pays a higher dividend?

    Krystal Biotech pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.

    Is Krystal Biotech bigger than its competitors?

    No. Krystal Biotech is 7th by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.